{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:53:23Z","timestamp":1762102403668,"version":"3.41.2"},"reference-count":196,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.00516","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T08:40:02Z","timestamp":1558082402000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Autoimmune Channelopathies at Neuromuscular Junction"],"prefix":"10.3389","volume":"10","author":[{"given":"Kun","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-Bei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,5,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.expneurol.2015.01.007","article-title":"Electrophysiological analysis of neuromuscular synaptic function in myasthenia gravis patients and animal models","volume":"270","author":"Plomp","year":"2015","journal-title":"Exp Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e60438","DOI":"10.1371\/journal.pone.0060438","article-title":"Antibody repertoire in paraneoplastic cerebellar degeneration and small cell lung cancer","volume":"8","author":"Sabater","year":"2013","journal-title":"PLoS ONE."},{"key":"B3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/mus.24632","article-title":"Isaacs syndrome: a review","volume":"52","author":"Ahmed","year":"2015","journal-title":"Muscle Nerve."},{"key":"B4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jaut.2014.01.003","article-title":"Diagnostic and clinical classification of autoimmune myasthenia gravis","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1242\/dev.038711","article-title":"To build a synapse: signaling pathways in neuromuscular junction assembly","volume":"137","author":"Wu","year":"2010","journal-title":"Development."},{"key":"B6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BF03020488","article-title":"Calcium channels\u2013basic aspects of their structure, function and gene encoding; anesthetic action on the channels\u2013a review","volume":"49","author":"Yamakage","year":"2002","journal-title":"Can J Anaesth."},{"key":"B7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1124\/pr.57.4.5","article-title":"International Union of Pharmacology. XLVIII Nomenclature and structure-function relationships of voltage-gated calcium channels","volume":"57","author":"Catterall","year":"2005","journal-title":"Pharmacol Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/383431a0","article-title":"Calcium influx and transmitter release in a fast CNS synapse","volume":"383","author":"Borst","year":"1996","journal-title":"Nature."},{"key":"B9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrn3125","article-title":"Nanodomain coupling between Ca(2)(+) channels and sensors of exocytosis at fast mammalian synapses","volume":"13","author":"Eggermann","year":"2011","journal-title":"Nat Rev Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s00249-003-0363-2","article-title":"The roles of intracellular regions in the activation of voltage-dependent potassium channels","volume":"33","author":"Wray","year":"2004","journal-title":"Eur Biophys J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0896-6273(92)90166-B","article-title":"Subcellular segregation of two A-type K+ channel proteins in rat central neurons","volume":"9","author":"Sheng","year":"1992","journal-title":"Neuron."},{"key":"B12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1126\/science.280.5360.69","article-title":"The structure of the potassium channel: molecular basis of K+ conduction and selectivity","volume":"280","author":"Doyle","year":"1998","journal-title":"Science."},{"key":"B13","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1212\/WNL.54.3.771","article-title":"Morvan's syndrome associated with voltage-gated K+ channel antibodies","volume":"54","author":"Barber","year":"2000","journal-title":"Neurology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1176\/appi.neuropsych.13020022","article-title":"Treatment of VGKC complex antibody-associated limbic encephalitis: a systematic review","volume":"25","author":"Radja","year":"2013","journal-title":"J Neuropsychiatry Clin Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1083\/jcb.82.1.150","article-title":"Organization of acetylcholine receptors in quick-frozen, deep-etched, and rotary-replicated Torpedo postsynaptic membrane","volume":"82","author":"Heuser","year":"1979","journal-title":"J Cell Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.cell.2011.02.037","article-title":"SnapShot: neuromuscular junction","volume":"144","author":"Burden","year":"2011","journal-title":"Cell."},{"key":"B17","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0092-8674(00)81252-0","article-title":"Agrin acts via a MuSK receptor complex","volume":"85","author":"Glass","year":"1996","journal-title":"Cell."},{"key":"B18","doi-asserted-by":"publisher","first-page":"ENEURO","DOI":"10.1523\/ENEURO.0232-17.2017","article-title":"Super-resolution microscopy reveals a nanoscale organization of acetylcholine receptors for trans-synaptic alignment at neuromuscular synapses","volume":"4","author":"York","year":"2017","journal-title":"eNeuro."},{"key":"B19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.bcp.2017.12.008","article-title":"The wonderland of neuronal nicotinic acetylcholine receptors","volume":"151","author":"Bertrand","year":"2018","journal-title":"Biochem Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.pbiomolbio.2003.09.002","article-title":"Ligand-gated ion channels: mechanisms underlying ion selectivity","volume":"86","author":"Keramidas","year":"2004","journal-title":"Prog Biophys Mol Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0188-4409(99)00087-9","article-title":"Nicotine, brain nicotinic receptors, and neuropsychiatric disorders","volume":"31","author":"Mihailescu","year":"2000","journal-title":"Arch Med Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/321406a0","article-title":"Molecular distinction between fetal and adult forms of muscle acetylcholine receptor","volume":"321","author":"Mishina","year":"1986","journal-title":"Nature."},{"key":"B23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/dbio.1996.0253","article-title":"Maturation of the acetylcholine receptor in skeletal muscle: regulation of the AChR gamma-to-epsilon switch","volume":"179","author":"Missias","year":"1996","journal-title":"Dev Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.bbrc.2005.04.081","article-title":"The acetylcholine receptor gamma-to-epsilon switch occurs in individual endplates","volume":"331","author":"Yumoto","year":"2005","journal-title":"Biochem Biophys Res Commun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1113\/jphysiol.1980.sp013275","article-title":"A post-natal decrease in acetylcholine channel open time at rat end-plates","volume":"303","author":"Fischbach","year":"1980","journal-title":"J Physiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0896-6273(88)90195-X","article-title":"Immunological evidence for a change in subunits of the acetylcholine receptor in developing and denervated rat muscle","volume":"1","author":"Gu","year":"1988","journal-title":"Neuron."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1152\/jn.00879.2014","article-title":"Transmitter release is evoked with low probability predominately by calcium flux through single channel openings at the frog neuromuscular junction","volume":"113","author":"Luo","year":"2015","journal-title":"J Neurophysiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/neu.480160106","article-title":"Regulation of calcium influx into buccal muscles of Aplysia by acetylcholine and serotonin","volume":"16","author":"Ram","year":"1985","journal-title":"J Neurobiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/0896-6273(93)90214-C","article-title":"Single calcium channels and acetylcholine release at a presynaptic nerve terminal","volume":"11","author":"Stanley","year":"1993","journal-title":"Neuron."},{"key":"B30","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1113\/jphysiol.1975.sp011103","article-title":"The number of transmitter molecules in a quantum: an estimate from iontophoretic application of acetylcholine at the neuromuscular synapse","volume":"251","author":"Kuffler","year":"1975","journal-title":"J Physiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1017\/S0033583513000061","article-title":"Nicotinic acetylcholine receptor and the structural basis of neuromuscular transmission: insights from Torpedo postsynaptic membranes","volume":"46","author":"Unwin","year":"2013","journal-title":"Q Rev Biophys."},{"key":"B32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1073\/pnas.0406777102","article-title":"A speed limit for conformational change of an allosteric membrane protein","volume":"102","author":"Chakrapani","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"B33","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S0006-3495(95)80209-2","article-title":"The conductance of the muscle nicotinic receptor channel changes rapidly upon gating","volume":"68","author":"Maconochie","year":"1995","journal-title":"Biophys J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0301-0082(00)00055-1","article-title":"Safety factor at the neuromuscular junction","volume":"64","author":"Wood","year":"2001","journal-title":"Prog Neurobiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1002\/mus.10143","article-title":"Safety margin at single neuromuscular junctions","volume":"11","author":"Trontelj","year":"2002","journal-title":"Muscle Nerve Suppl."},{"key":"B36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1113\/jphysiol.1967.sp008237","article-title":"The margin of safety of neuromuscular transmission","volume":"191","author":"Paton","year":"1967","journal-title":"J Physiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1212\/01.CON.0000455873.30438.9b","article-title":"Myasthenia gravis and Lambert-Eaton myasthenic syndrome","volume":"20","author":"Sanders","year":"2014","journal-title":"Continuum (Minneap Minn)."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/S1474-4422(11)70245-9","article-title":"Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies","volume":"10","author":"Titulaer","year":"2011","journal-title":"Lancet Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1001\/jama.1957.02970480021005","article-title":"Electromyography and electric stimulation of nerves in diseases of motor unit; observations on myasthenic syndrome associated with malignant tumors","volume":"163","author":"Eaton","year":"1957","journal-title":"J Am Med Assoc."},{"key":"B40","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/brain\/111.3.577","article-title":"The Lambert-Eaton myasthenic syndrome. A review of 50 cases","volume":"111","author":"O'neill","year":"1988","journal-title":"Brain."},{"key":"B41","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1007\/s00415-003-1063-7","article-title":"The epidemiology of myasthenia gravis, Lambert-Eaton myasthenic syndrome and their associated tumours in the northern part of the province of South Holland","volume":"250","author":"Wirtz","year":"2003","journal-title":"J Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1212\/01.WNL.0000130254.27019.14","article-title":"The epidemiology of the Lambert-Eaton myasthenic syndrome in the Netherlands","volume":"63","author":"Wirtz","year":"2004","journal-title":"Neurology."},{"key":"B43","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/mus.25520","article-title":"Lambert-Eaton myasthenic syndrome: epidemiology and therapeutic response in the national veterans affairs population","volume":"56","author":"Abenroth","year":"2017","journal-title":"Muscle Nerve."},{"key":"B44","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jneuroim.2008.05.025","article-title":"The Lambert-Eaton myasthenic syndrome 1988\u20132008: a clinical picture in 97 patients","author":"Titulaer","year":"2008","journal-title":"J Neuroimmunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.pediatrneurol.2013.08.009","article-title":"Lambert-Eaton syndrome, an unrecognized treatable pediatric neuromuscular disorder: three patients and literature review","volume":"50","author":"Hajjar","year":"2014","journal-title":"Pediatr Neurol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1196\/annals.1405.030","article-title":"Lambert-Eaton myasthenic syndrome: tumor versus nontumor forms","volume":"1132","author":"Titulaer","year":"2008","journal-title":"Ann N Y Acad Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1200\/JCO.2010.32.0440","article-title":"Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS","volume":"29","author":"Titulaer","year":"2011","journal-title":"J Clin Oncol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/WNO.0000000000000258","article-title":"Lambert-Eaton Myasthenic syndrome: ocular signs and symptoms","volume":"36","author":"Young","year":"2016","journal-title":"J Neuroophthalmol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.clinph.2013.02.115","article-title":"Myopathic EMG findings and type II muscle fiber atrophy in patients with Lambert-Eaton myasthenic syndrome","volume":"124","author":"Crone","year":"2013","journal-title":"Clin Neurophysiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1212\/WNL.46.4.1143","article-title":"Acute ventilatory failure in Lambert-Eaton myasthenic syndrome and its response to 3,4-diaminopyridine","volume":"46","author":"Smith","year":"1996","journal-title":"Neurology."},{"key":"B51","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0303-8467(02)00054-9","article-title":"Differences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: an analysis of 227 published cases","volume":"104","author":"Wirtz","year":"2002","journal-title":"Clin Neurol Neurosurg."},{"key":"B52","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jneuroim.2009.09.017","article-title":"Managing non-paraneoplastic Lambert-Eaton myasthenic syndrome: clinical characteristics in 25 German patients","volume":"217","author":"Pellkofer","year":"2009","journal-title":"J Neuroimmunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1590\/S0004-282X2010000600004","article-title":"Non-paraneoplastic Lambert-Eaton myasthenic syndrome: a brief review of 10 cases","volume":"68","author":"Lorenzoni","year":"2010","journal-title":"Arq Neuropsiquiatr."},{"key":"B54","doi-asserted-by":"publisher","first-page":"7636","DOI":"10.1073\/pnas.80.24.7636","article-title":"Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones","volume":"80","author":"Fukunaga","year":"1983","journal-title":"Proc Natl Acad Sci USA."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1056\/NEJM199506013322203","article-title":"Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes","volume":"332","author":"Lennon","year":"1995","journal-title":"N Engl J Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0022-510X(95)00162-U","article-title":"Antibodies to recombinant synaptotagmin and calcium channel subtypes in Lambert-Eaton myasthenic syndrome","volume":"133","author":"Takamori","year":"1995","journal-title":"J Neurol Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0022-510X(96)05303-8","article-title":"Incidence of serum anti-P\/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome","volume":"147","author":"Motomura","year":"1997","journal-title":"J Neurol Sci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1007\/s00415-018-8959-8","article-title":"Low specificity of voltage-gated calcium channel antibodies in Lambert-Eaton myasthenic syndrome: a call for caution","volume":"265","author":"Di Lorenzo","year":"2018","journal-title":"J Neurol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/mus.25027","article-title":"P\/Q- and N-type calcium-channel antibodies: Oncological, neurological, and serological accompaniments","volume":"54","author":"Zalewski","year":"2016","journal-title":"Muscle Nerve."},{"key":"B60","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1212\/WNL.44.2.334","article-title":"Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient","volume":"44","author":"Johnston","year":"1994","journal-title":"Neurology."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/S0025-6196(12)61144-6","article-title":"Molecular diversity of neuronal-type calcium channels identified in small cell lung carcinoma","volume":"67","author":"Oguro-Okano","year":"1992","journal-title":"Mayo Clin Proc."},{"key":"B62","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jneuroim.2005.03.020","article-title":"Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes","volume":"165","author":"Graus","year":"2005","journal-title":"J Neuroimmunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jns.2016.09.002","article-title":"Prevalence of anti-SOX1 reactivity in various neurological disorders","volume":"369","author":"Berger","year":"2016","journal-title":"J Neurol Sci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1749-6632.2012.06772.x","article-title":"SOX1 antibodies in Lambert-Eaton myasthenic syndrome and screening for small cell lung carcinoma","volume":"1275","author":"Lipka","year":"2012","journal-title":"Ann N Y Acad Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1212\/01.wnl.0000281663.81079.24","article-title":"SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome","volume":"70","author":"Sabater","year":"2008","journal-title":"Neurology."},{"key":"B66","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1200\/JCO.2008.20.6169","article-title":"SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival","volume":"27","author":"Titulaer","year":"2009","journal-title":"J Clin Oncol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1212\/01.WNL.0000037485.56217.5F","article-title":"Seronegative Lambert-Eaton myasthenic syndrome: study of 110 Japanese patients","volume":"59","author":"Nakao","year":"2002","journal-title":"Neurology."},{"key":"B68","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s10072-014-1637-4","article-title":"Italian recommendations for Lambert-Eaton myasthenic syndrome (LEMS) management","volume":"35","author":"Evoli","year":"2014","journal-title":"Neurol Sci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/mus.1139","article-title":"Practice parameter for repetitive nerve stimulation and single fiber EMG evaluation of adults with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: summary statement","volume":"24","author":"Medicine","year":"2001","journal-title":"Muscle Nerve."},{"key":"B70","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/mus.20389","article-title":"Electrophysiological diagnostic criteria of Lambert-Eaton myasthenic syndrome","volume":"32","author":"Oh","year":"2005","journal-title":"Muscle Nerve."},{"key":"B71","doi-asserted-by":"publisher","first-page":"4276","DOI":"10.1200\/JCO.2008.17.5133","article-title":"Screening for small-cell lung cancer: a follow-up study of patients with Lambert-Eaton myasthenic syndrome","volume":"26","author":"Titulaer","year":"2008","journal-title":"J Clin Oncol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1468-1331.2010.03220.x","article-title":"Screening for tumours in paraneoplastic syndromes: report of an EFNS task force","volume":"18","author":"Titulaer","year":"2011","journal-title":"Eur J Neurol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/mus.21422","article-title":"3,4-Diaminopyridine is more effective than placebo in a randomized, double-blind, cross-over drug study in LEMS","volume":"40","author":"Oh","year":"2009","journal-title":"Muscle Nerve."},{"key":"B74","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2147\/NDT.S10464","article-title":"Update on treatment options for Lambert-Eaton myasthenic syndrome: focus on use of amifampridine","volume":"7","author":"Lindquist","year":"2011","journal-title":"Neuropsychiatr Dis Treat."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1212\/CON.0000000000000415","article-title":"Myasthenia Gravis and Lambert-Eaton Myasthenic syndrome","volume":"22","author":"Nicolle","year":"2016","journal-title":"Continuum (Minneap Minn)."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003279.pub3","article-title":"Treatment for Lambert-Eaton myasthenic syndrome","author":"Keogh","year":"2011","journal-title":"Cochrane Database Syst Rev."},{"key":"B77","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s00415-009-5442-6","article-title":"3,4-diaminopyridine safety in clinical practice: an observational, retrospective cohort study","volume":"257","author":"Flet","year":"2010","journal-title":"J Neurol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1517\/14656566.7.10.1323","article-title":"Available treatment options for the management of Lambert-Eaton myasthenic syndrome","volume":"7","author":"Verschuuren","year":"2006","journal-title":"Expert Opin Pharmacother."},{"key":"B79","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/clpt.2009.35","article-title":"Efficacy of 3,4-diaminopyridine and pyridostigmine in the treatment of Lambert-Eaton myasthenic syndrome: a randomized, double-blind, placebo-controlled, crossover study","volume":"86","author":"Wirtz","year":"2009","journal-title":"Clin Pharmacol Ther."},{"key":"B80","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1212\/WNL.34.4.480","article-title":"Plasma exchange and immunosuppressive drug treatment in the Lambert-Eaton myasthenic syndrome","volume":"34","author":"Newsom-Davis","year":"1984","journal-title":"Neurology."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1212\/WNL.0b013e31824de293","article-title":"Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"78","author":"Patwa","year":"2012","journal-title":"Neurology."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1212\/WNL.42.7.1422","article-title":"Clinical and electrophysiologic improvement in Lambert-Eaton syndrome with intravenous immunoglobulin therapy","volume":"42","author":"Bird","year":"1992","journal-title":"Neurology."},{"key":"B83","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1212\/WNL.47.3.678","article-title":"Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome","volume":"47","author":"Bain","year":"1996","journal-title":"Neurology."},{"key":"B84","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.nmd.2014.08.006","article-title":"Efficacy of intravenous immunoglobulin for treatment of Lambert-Eaton myasthenic syndrome without anti-presynaptic P\/Q-type voltage-gated calcium channel antibodies: a case report","volume":"25","author":"Okada","year":"2015","journal-title":"Neuromuscul Disord."},{"key":"B85","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1136\/pgmj.75.887.516","article-title":"Lambert-Eaton myasthenic syndrome","volume":"75","author":"Seneviratne","year":"1999","journal-title":"Postgrad Med J."},{"key":"B86","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1046\/j.1526-0968.2000.004004287.x","article-title":"Apheresis treatment in Lambert-Eaton myasthenic syndrome","volume":"4","author":"Motomura","year":"2000","journal-title":"Ther Apher."},{"key":"B87","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1136\/jnnp.24.4.319","article-title":"A Syndrome of continuous muscle-fibre activity","volume":"24","author":"Isaacs","year":"1961","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1212\/CON.0000000000000520","article-title":"Peripheral nerve hyperexcitability syndromes","volume":"23","author":"Sawlani","year":"2017","journal-title":"Continuum (Minneap Minn)."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1093\/brain\/awf178","article-title":"Phenotypic variants of autoimmune peripheral nerve hyperexcitability","volume":"125","author":"Hart","year":"2002","journal-title":"Brain."},{"key":"B90","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1016\/j.bbamem.2015.04.003","article-title":"Autoimmune channelopathies in paraneoplastic neurological syndromes","volume":"1848","author":"Joubert","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"B91","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/nau.23336","article-title":"Urinary manifestations in Isaacs's syndrome. Our experience in 8 cases","volume":"37","author":"Gonzalez Primomo","year":"2018","journal-title":"Neurourol Urodyn."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1212\/WNL.41.7.1021","article-title":"Cramp-fasciculation syndrome: a treatable hyperexcitable peripheral nerve disorder","volume":"41","author":"Tahmoush","year":"1991","journal-title":"Neurology."},{"key":"B93","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/ana.410410215","article-title":"Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia","volume":"41","author":"Hart","year":"1997","journal-title":"Ann Neurol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1016\/j.clinph.2006.03.008","article-title":"Neuromyotonia","volume":"117","author":"Maddison","year":"2006","journal-title":"Clin Neurophysiol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/brain\/116.2.453","article-title":"Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Report of five cases and literature review","volume":"116","author":"Newsom-Davis","year":"1993","journal-title":"Brain."},{"key":"B96","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1001\/archneur.1970.00480230048005","article-title":"Generalized muscular stiffness, fasciculations, and myokymia of peripheral nerve origin","volume":"22","author":"Wallis","year":"1970","journal-title":"Arch Neurol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archneur.1983.04050040071012","article-title":"Isaacs' syndrome with muscle hypertrophy reversed by phenytoin therapy","volume":"40","author":"Zisfein","year":"1983","journal-title":"Arch Neurol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1002\/mus.10148","article-title":"Isaacs' syndrome as a potassium channelopathy of the nerve","volume":"11","author":"Arimura","year":"2002","journal-title":"Muscle Nerve Suppl."},{"key":"B99","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/mus.10266","article-title":"Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability","volume":"26","author":"Vernino","year":"2002","journal-title":"Muscle Nerve."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1212\/WNL.0000000000002637","article-title":"The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies","volume":"86","author":"Van Sonderen","year":"2016","journal-title":"Neurology."},{"key":"B101","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s10067-016-3499-z","article-title":"Neuromyotonia as an unusual neurological complication of primary Sjogren's syndrome: case report and literature review","volume":"36","author":"Xiao","year":"2017","journal-title":"Clin Rheumatol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.clinph.2005.03.023","article-title":"The origin of spontaneous discharges in acquired neuromyotonia","volume":"116","author":"Arimura","year":"2005","journal-title":"A Macro EMG study Clin Neurophysiol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/B978-0-444-63432-0.00011-6","article-title":"Voltage-gated potassium channel-complex autoimmunity and associated clinical syndromes","volume":"133","author":"Irani","year":"2016","journal-title":"Handb Clin Neurol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain."},{"key":"B106","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jocn.2017.02.063","article-title":"Isaacs syndrome with CASPR2 antibody: a series of three cases","volume":"41","author":"Song","year":"2017","journal-title":"J Clin Neurosci."},{"key":"B107","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1001\/jamaneurol.2013.592","article-title":"Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping","volume":"70","author":"Klein","year":"2013","journal-title":"JAMA Neurol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0002-9629(15)40732-3","article-title":"Acquired neuromyotonia: a new autoantibody-mediated neuronal potassium channelopathy","volume":"319","author":"Hart","year":"2000","journal-title":"Am J Med Sci."},{"key":"B109","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/j.1600-0404.1980.tb01486.x","article-title":"Electromyographic and nerve conduction findings in a patient with neuromyotonia, normocalcemic tetany and small-cell lung cancer","volume":"61","author":"Partanen","year":"1980","journal-title":"Acta Neurol Scand."},{"key":"B110","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1136\/jnnp-2013-305218","article-title":"Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre","volume":"85","author":"Paterson","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B111","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s00415-004-0331-5","article-title":"Myokymia and neuromyotonia 2004","volume":"251","author":"Gutmann","year":"2004","journal-title":"J Neurol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1212\/WNL.0b013e31827f0fa1","article-title":"Teaching Video NeuroImages: myokymia and nerve hyperexcitability as components of Morvan syndrome due to malignant thymoma","volume":"80","author":"Lukas","year":"2013","journal-title":"Neurology."},{"key":"B113","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1179\/1743132815Y.0000000006","article-title":"Paraneoplastic nerve hyperexcitability","volume":"37","author":"Liebenthal","year":"2015","journal-title":"Neurol Res."},{"key":"B114","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/mus.20536","article-title":"Clinical electrophysiological characterization of the acquired neuromyotonia phenotype of autoimmune peripheral nerve hyperexcitability","volume":"33","author":"Maddison","year":"2006","journal-title":"Muscle Nerve."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1001\/jamaneurol.2013.2863","article-title":"Acquired neuromyotonia heralding recurrent thymoma in myasthenia gravis","volume":"70","author":"Fleisher","year":"2013","journal-title":"JAMA Neurol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s13760-016-0688-0","article-title":"Isaacs' syndrome and Hodgkin lymphoma: a rare association","volume":"117","author":"London","year":"2017","journal-title":"Acta Neurol Belg."},{"key":"B117","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/mus.880170106","article-title":"Idiopathic generalized myokymia","volume":"17","author":"Jamieson","year":"1994","journal-title":"Muscle Nerve."},{"key":"B118","first-page":"1026","article-title":"Gabapentin suppresses ectopic nerve discharges and reverses allodynia in neuropathic rats","volume":"288","author":"Pan","year":"1999","journal-title":"J Pharmacol Exp Ther."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.2165\/00003495-200060050-00005","article-title":"Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy","volume":"60","author":"Tremont-Lukats","year":"2000","journal-title":"Drugs."},{"key":"B120","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/mus.20591","article-title":"Isaacs' syndrome: clinical and electrophysiological response to gabapentin","volume":"34","author":"Dhand","year":"2006","journal-title":"Muscle Nerve."},{"key":"B121","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0022-510X(00)00407-X","article-title":"Neuromyotonia: autoimmune pathogenesis and response to immune modulating therapy","volume":"181","author":"Hayat","year":"2000","journal-title":"J Neurol Sci."},{"key":"B122","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/jca.21233","article-title":"Plasma exchange as a therapeutic option in patients with neurologic symptoms due to antibodies to voltage-gated potassium channels: a report of five cases and review of the literature","volume":"27","author":"Jaben","year":"2012","journal-title":"J Clin Apher."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1212\/WNL.0b013e3181ad53c2","article-title":"Seropositive myasthenia gravis: a nationwide epidemiologic study","volume":"73","author":"Heldal","year":"2009","journal-title":"Neurology."},{"key":"B125","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1159\/000336002","article-title":"Epidemiology and geographical variation of myasthenia gravis in the province of Pavia, Italy","volume":"38","author":"Montomoli","year":"2012","journal-title":"Neuroepidemiology."},{"key":"B126","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1159\/000342777","article-title":"Epidemiological study of adult-onset myasthenia gravis in the area of Belgrade (Serbia) in the period 1979\u20132008","volume":"40","author":"Lavrnic","year":"2013","journal-title":"Neuroepidemiology."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1111\/j.1468-1331.2010.03089x","article-title":"Myasthenia gravis requiring pyridostigmine treatment in a national population cohort","volume":"17","author":"Andersen","year":"2010","journal-title":"Eur J Neurol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1136\/jnnp.2006.102517","article-title":"Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands","volume":"78","author":"Niks","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B129","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/mus.22006","article-title":"Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts","volume":"44","author":"Guptill","year":"2011","journal-title":"Muscle Nerve."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1007\/s00415-011-5964-6","article-title":"Familial autoimmune MuSK positive myasthenia gravis","volume":"258","author":"Corda","year":"2011","journal-title":"J Neurol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s10072-011-0818-7","article-title":"A retrospective review of 15 patients with familial myasthenia gravis over a period of 25 years","volume":"33","author":"Feng","year":"2012","journal-title":"Neurol Sci."},{"key":"B132","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/S0960-8966(02)00137-2","article-title":"Limb-girdle myasthenia: clinical, electrophysiological and morphological features in familial and autoimmune cases","volume":"12","author":"Rodolico","year":"2002","journal-title":"Neuromuscul Disord."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1212\/WNL.37.12.1854","article-title":"Myasthenia gravis: population differences in disease expression and acetylcholine receptor antibody titers between Chinese and Caucasians","volume":"37","author":"Chiu","year":"1987","journal-title":"Neurology."},{"key":"B135","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1136\/jnnp.2006.100545","article-title":"Clinical and serological study of myasthenia gravis in HuBei Province, China","volume":"78","author":"Zhang","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B136","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1055\/s-2004-829591","article-title":"Autoimmune myasthenia gravis in childhood","volume":"24","author":"Andrews","year":"2004","journal-title":"Semin Neurol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology."},{"key":"B138","doi-asserted-by":"publisher","first-page":"783","DOI":"10.4103\/0028-3886.185401","article-title":"Myasthenia gravis accompanied by Graves' disease, thyrotoxic hypokalemic periodic paralysis and thymic hyperplasia","volume":"64","author":"Huang","year":"2016","journal-title":"Neurol India."},{"key":"B139","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.expneurol.2015.02.010","article-title":"Thymoma related myasthenia gravis in humans and potential animal models","volume":"270","author":"Marx","year":"2015","journal-title":"Exp Neurol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1196\/annals.1405.021","article-title":"Autoimmunizing mechanisms in thymoma and thymus","volume":"1132","author":"Willcox","year":"2008","journal-title":"Ann N Y Acad Sci."},{"key":"B141","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1196\/annals.1254.059","article-title":"Three forms of immune myasthenia","volume":"998","author":"Agius","year":"2003","journal-title":"Ann N Y Acad Sci."},{"key":"B142","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0165-5728(95)00106-C","article-title":"Thymomas express epitopes shared by the ryanodine receptor","volume":"62","author":"Mygland","year":"1995","journal-title":"J Neuroimmunol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia gravis\u2013autoantibody characteristics and their implications for therapy","volume":"12","author":"Gilhus","year":"2016","journal-title":"Nat Rev Neurol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.autrev.2013.03.001","article-title":"Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4","volume":"12","author":"Verschuuren","year":"2013","journal-title":"Autoimmun Rev."},{"key":"B145","doi-asserted-by":"publisher","first-page":"e108327","DOI":"10.1371\/journal.pone.0108327","article-title":"Direct proof of the in vivo pathogenic role of the AChR autoantibodies from myasthenia gravis patients","volume":"9","author":"Kordas","year":"2014","journal-title":"PLoS ONE."},{"key":"B146","doi-asserted-by":"publisher","first-page":"4926","DOI":"10.1523\/JNEUROSCI.3381-14.2015","article-title":"MuSK frizzled-like domain is critical for mammalian neuromuscular junction formation and maintenance","volume":"35","author":"Messeant","year":"2015","journal-title":"J Neurosci"},{"key":"B147","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1749-6632.2012.06808.x","article-title":"Pathogenic IgG4 subclass autoantibodies in MuSK myasthenia gravis","volume":"1275","author":"Plomp","year":"2012","journal-title":"Ann N Y Acad Sci."},{"key":"B148","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/archneurol.2011.2393","article-title":"Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis","volume":"69","author":"Zhang","year":"2012","journal-title":"Arch Neurol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coi.2017.07.006","article-title":"Pathophysiology and immunological profile of myasthenia gravis and its subgroups","volume":"49","author":"Romi","year":"2017","journal-title":"Curr Opin Immunol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"13892","DOI":"10.1523\/JNEUROSCI.1733-14.2014","article-title":"LRP4 is critical for neuromuscular junction maintenance","volume":"34","author":"Barik","year":"2014","journal-title":"J Neurosci."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1212\/WNL.0000000000000478","article-title":"Anti-agrin autoantibodies in myasthenia gravis","volume":"82","author":"Gasperi","year":"2014","journal-title":"Neurology."},{"key":"B152","doi-asserted-by":"publisher","first-page":"e91816","DOI":"10.1371\/journal.pone.0091816","article-title":"Autoantibodies to agrin in myasthenia gravis patients","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS ONE."},{"key":"B153","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.mod.2012.09.004","article-title":"The neuromuscular junction: selective remodeling of synaptic regulators at the nerve\/muscle interface","volume":"130","author":"Witzemann","year":"2013","journal-title":"Mech Dev."},{"key":"B154","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/ene.12359","article-title":"EFNS\/ENS Guidelines for the treatment of ocular myasthenia","volume":"21","author":"Kerty","year":"2014","journal-title":"Eur J Neurol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s00415-019-09225-z","article-title":"Thymomatous myasthenia gravis: novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity","volume":"266","author":"Massa","year":"2019","journal-title":"J Neurol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1136\/jnnp.48.12.1246","article-title":"Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays","volume":"48","author":"Vincent","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B157","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1212\/WNL.34.1.66","article-title":"Anti-AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis","volume":"34","author":"Berrih","year":"1984","journal-title":"Neurology."},{"key":"B158","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain."},{"key":"B159","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/ana.20386","article-title":"Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG","volume":"57","author":"Leite","year":"2005","journal-title":"Ann Neurol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00415-011-6194-7","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis","volume":"259","author":"Pevzner","year":"2012","journal-title":"J Neurol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1001\/jamaneurol.2016.2032","article-title":"Clinical characteristics of patients with double-seronegative myasthenia gravis and antibodies to cortactin","volume":"73","author":"Cortes-Vicente","year":"2016","journal-title":"JAMA Neurol."},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-019-03746-1","article-title":"Italian recommendations for the diagnosis and treatment of myasthenia gravis","author":"Evoli","year":"2019","journal-title":"Neurol Sci."},{"key":"B163","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/mus.880130302","article-title":"Edrophonium responsiveness not necessarily diagnostic of myasthenia gravis","volume":"13","author":"Oh","year":"1990","journal-title":"Muscle Nerve."},{"key":"B164","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ncl.2018.01.010","article-title":"Diagnosis of myasthenia gravis","volume":"36","author":"Pasnoor","year":"2018","journal-title":"Neurol Clin."},{"key":"B165","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/mus.880160512","article-title":"Muscle fiber conduction velocity changes with length","volume":"16","author":"Trontelj","year":"1993","journal-title":"Muscle Nerve."},{"key":"B166","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/mus.880150322","article-title":"Single fiber EMG in the frontalis muscle in ocular myasthenia: specificity and sensitivity","volume":"15","author":"Rouseev","year":"1992","journal-title":"Muscle Nerve"},{"key":"B167","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/mus.20435","article-title":"Single-fiber EMG with a concentric needle electrode: validation in myasthenia gravis","volume":"33","author":"Sarrigiannis","year":"2006","journal-title":"Muscle Nerve."},{"key":"B168","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/mus.20921","article-title":"Single-fiber electromyography of masseter muscle in myasthenia gravis","volume":"37","author":"Khuraibet","year":"2008","journal-title":"Muscle Nerve."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/S1388-2457(00)00307-2","article-title":"SFEMG in ocular myasthenia gravis diagnosis","volume":"111","author":"Padua","year":"2000","journal-title":"Clin Neurophysiol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1002\/mus.10141","article-title":"Clinical impact of single-fiber electromyography","volume":"11","author":"Sanders","year":"2002","journal-title":"Muscle Nerve Suppl."},{"key":"B171","first-page":"19424","article-title":"Determination of the normative values of the masseter muscle by single-fiber electromyography in myasthenia gravis patients","volume":"8","author":"Shi","year":"2015","journal-title":"Int J Clin Exp Med."},{"key":"B172","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1212\/WNL.31.4_Part_2.386","article-title":"Myasthenia gravis: relation between jitter in single-fiber EMG and antibody to acetylcholine receptor","volume":"31","author":"Konishi","year":"1981","journal-title":"Neurology."},{"key":"B173","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/mus.25174","article-title":"Single fiber EMG as a prognostic tool in myasthenia gravis","volume":"54","author":"Baruca","year":"2016","journal-title":"Muscle Nerve."},{"key":"B174","doi-asserted-by":"publisher","first-page":"e230","DOI":"10.1016\/j.crad.2014.01.005","article-title":"Imaging of thymus in myasthenia gravis: from thymic hyperplasia to thymic tumor","volume":"69","author":"Priola","year":"2014","journal-title":"Clin Radiol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1001\/archneur.60.2.243","article-title":"Development of generalized disease at 2 years in patients with ocular myasthenia gravis","volume":"60","author":"Kupersmith","year":"2003","journal-title":"Arch Neurol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1007\/s00415-009-5120-8","article-title":"Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-up","volume":"256","author":"Kupersmith","year":"2009","journal-title":"J Neurol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1212\/WNL.50.6.1778","article-title":"A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group","volume":"50","author":"Palace","year":"1998","journal-title":"Neurology."},{"key":"B178","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1212\/01.wnl.0000312374.95186.cc","article-title":"An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis","volume":"71","author":"Sanders","year":"2008","journal-title":"Neurology."},{"key":"B179","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jns.2009.02.357","article-title":"Rituximab for myasthenia gravis: three case reports and review of the literature","volume":"280","author":"Stieglbauer","year":"2009","journal-title":"J Neurol Sci."},{"key":"B180","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1136\/jnnp-2011-300148","article-title":"Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis","volume":"82","author":"Yoshikawa","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26447","article-title":"Long-term safety and efficacy of eculizumab in generalized myasthenia gravis","author":"Muppidi","year":"2019","journal-title":"Muscle Nerve."},{"key":"B182","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jocn.2019.02.004","article-title":"Effectiveness and safety of tacrolimus therapy for myasthenia gravis: a single arm meta-analysis","volume":"63","author":"Wang","year":"2019","journal-title":"J Clin Neurosci."},{"key":"B183","unstructured":"IncAP\n          Soliris (eculizumab): US Prescribing Information2015"},{"key":"B184","unstructured":"SasAE\n          Soliris (eculizumab): Summary of Product Characteristics2017"},{"key":"B185","unstructured":"WelfareJMOHLA\n          Soliris (eculizumab): Japanese Prescribing Information2017"},{"key":"B186","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/cns.13110","article-title":"Immunosuppressive and monoclonal antibody treatment for myasthenia gravis: a network meta-analysis","volume":"25","author":"Wang","year":"2019","journal-title":"CNS Neurosci Ther."},{"key":"B187","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.expneurol.2019.03.001","article-title":"Efgartigimod improves muscle weakness in a mouse model for muscle-specific kinase myasthenia gravis","volume":"317","author":"Huijbers","year":"2019","journal-title":"Exp Neurol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"4","DOI":"10.21037\/atm.2018.11.66","article-title":"Who will benefit from thymectomy for myasthenia gravis? Is there any role for this procedure in elderly patients?","volume":"7","author":"Otsuka","year":"2019","journal-title":"Ann Transl Med."},{"key":"B189","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N Engl J Med."},{"key":"B190","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1474-4422(18)30392-2","article-title":"Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial","volume":"18","author":"Wolfe","year":"2019","journal-title":"Lancet Neurol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1097\/MOP.0b013e328365ad16","article-title":"Update on juvenile myasthenia gravis","volume":"25","author":"Liew","year":"2013","journal-title":"Curr Opin Pediatr."},{"key":"B192","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/ana.22139","article-title":"Comparative analysis of therapeutic options used for myasthenia gravis","volume":"68","author":"Mandawat","year":"2010","journal-title":"Ann Neurol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1212\/WNL.0b013e31821e5505","article-title":"Comparison of IVIg and PLEX in patients with myasthenia gravis","volume":"76","author":"Barth","year":"2011","journal-title":"Neurology."},{"key":"B194","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1016\/j.clinph.2014.06.031","article-title":"Lambert-Eaton myasthenic syndrome\u2013diagnosis, pathogenesis and therapy","volume":"125","author":"Hulsbrink","year":"2014","journal-title":"Clin Neurophysiol."},{"key":"B195","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/mus.880171103","article-title":"AAEM minimonograph #44: diseases associated with excess motor unit activity","volume":"17","author":"Auger","year":"1994","journal-title":"Muscle Nerve."},{"key":"B196","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1016\/j.pmrj.2013.03.016","article-title":"Neuromuscular junction disorders","volume":"5","author":"Liang","year":"2013","journal-title":"PM R."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00516\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T08:40:05Z","timestamp":1558082405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00516\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,17]]},"references-count":196,"alternative-id":["10.3389\/fneur.2019.00516"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.00516","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2019,5,17]]},"article-number":"516"}}